Strengths
Certara's software products are industry-leading, providing advanced biosimulation capabilities that enhance drug development efficiency.
The company boasts a strong track record, with 90% of new drug approvals by the FDA achieved by its clients over the past nine years.
Certara's comprehensive solutions integrate software, consulting, and regulatory services, offering a one-stop-shop for clients.
The firm has a large team of recognized experts in model-informed drug development, ensuring high-quality support for clients.
Certara's commitment to innovation is evident in its advanced data analytics and AI capabilities, which improve decision-making in drug development.
The company has successfully completed over 300 global regulatory submissions in the past five years, showcasing its expertise in regulatory affairs.
Certara's positioning as a trusted partner in the pharmaceutical industry enhances its brand reputation and client loyalty.
The company's focus on enhancing the quality and speed of regulatory submissions provides a competitive edge in the market.